Skip to main content
Premium Trial:

Request an Annual Quote

OncoMed Licenses MorphoSys HuCal Library to Help Develop Cancer Therapies

NEW YORK, June 7 (GenomeWeb News) - OncoMed Pharmaceuticals has licensed an antibody library from MorphoSys to research and develop therapeutic antibodies for the treatment of several cancers, the companies said today.

 

According to the terms of the agreement, OncoMed will gain access to MorphoSys' HuCal Gold library for two years in exchange for an up-front payment and annual user fees, the companies said.

 

The firms did not disclose additional financial details.

 

OncoMed will use the library to develop therapies against cancer stem cells in breast, lung, colon, prostate, and other cancers, the company said.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.